GlassScriptPhysician profile
Benedict L Garrett
NPI 1659476323
$2,325.71
in general payments reported to CMS, 2019-2025
16 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.80 · 2020: $17.53 · 2021: $188 · 2022: $695 · 2023: $396 · 2024: $544 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Education: $31.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.43 |
| Education | $31.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,623.13 | 2019-2025 | |
| Boston Scientific Corporation | $252.61 | 2023-2025 | Exalt Model D, General - Biliary Devices |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.25 | 2023-2024 | Xifaxan |
| Madrigal Pharmaceuticals | $53.09 | 2025 | Rezdiffra |
| Redhill Biopharma INC. | $38.38 | 2021-2022 | |
| Celltrion USA INC. | $31.58 | 2024 | Zymfentra |
| Janssen Biotech, INC. | $30.88 | 2023 | Stelara |
| Medtronic, INC. | $28.72 | 2021 | |
| Pfizer INC. | $27.66 | 2023 | |
| Genzyme Corporation | $27.14 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $25.31 | 2023 | Dupixent |
| Olympus America INC. | $21.65 | 2025 | Endoclot Phs |
| Aimmune Therapeutics, INC. | $20.07 | 2025 | Vowst |
| Merck Sharp & Dohme LLC | $18.23 | 2021 | |
| Intercept Pharmaceuticals, INC. | $17.53 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micro-Tech Endoscopy USA, INC. | $14.48 | 2025 | Lockado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benedict Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.